elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24652733-2AAD5BCE-53AF-4FD5-9A06-5F184BFF265B
Q24652733-2AAD5BCE-53AF-4FD5-9A06-5F184BFF265B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24652733-2AAD5BCE-53AF-4FD5-9A06-5F184BFF265B
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer
P2860
Q24652733-2AAD5BCE-53AF-4FD5-9A06-5F184BFF265B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24652733-2AAD5BCE-53AF-4FD5-9A06-5F184BFF265B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3241314c83b5eda115606c4d95d431d80f109fe
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer